Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species
- PMID: 17433786
- DOI: 10.1016/j.vph.2007.01.004
Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species
Abstract
Studies have shown that oxidized low density lipoprotein (ox-LDL) elicits both necrotic and apoptotic cell death and several mechanisms have been proposed. Ox-LDL induces reactive oxygen species (ROS), a second messenger that might be involved in apoptosis, formation in different types of cells including endothelial cells (ECs) and smooth muscle cells (SMCs). As lectin-like ox-LDL receptor-1 (LOX-1) was the main receptor for ox-LDL, this study was designed to determine whether the apoptosis induced by ox-LDL was mediated by LOX-1 in cultured human umbilical vein endothelial cells (HUVECs) and whether there is an association between LOX-1 mediated apoptosis and the production of ROS. After exposure to ox-LDL (50,100, and 150 microg/ml for 18 h), HUVECs exhibit typical apoptotic characteristics as determined by transmission electron microscopy and flow cytometry analysis in a dose-dependent pattern. Ox-LDL increases intracellular ROS formation including superoxide anion (O2-) and hydrogen peroxide (H2O2) in a dose-dependent and time-dependent manner. Pretreatment with anti-LOX-1 mAb, Vitamin C, apocynin or catalase significantly reduced ROS production and prevented ox-LDL-induced apoptosis, while indomethacin or allopurinol had no effect. These results suggest that LOX-1 mediates ox-LDL-induced apoptosis in endothelial cells and that ROS production and NADPH oxidase might play an important role in ox-LDL-induced apoptosis.
Similar articles
-
Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species.Fundam Clin Pharmacol. 2011 Oct;25(5):572-9. doi: 10.1111/j.1472-8206.2010.00885.x. Epub 2010 Nov 16. Fundam Clin Pharmacol. 2011. PMID: 21077940
-
LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells.Cardiovasc Res. 2009 Oct 1;84(1):127-36. doi: 10.1093/cvr/cvp177. Epub 2009 Jun 1. Cardiovasc Res. 2009. PMID: 19487339
-
[Effects of lecithin-like oxidized low-density lipoprotein receptor-1 on p38 mitogen-activated protein kinase induced by oxidized low-density lipoprotein in endothelial cells].Zhonghua Yi Xue Za Zhi. 2006 Jun 27;86(24):1697-700. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16854325 Chinese.
-
The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.Can J Cardiol. 2004 Aug;20 Suppl B:32B-36B. Can J Cardiol. 2004. PMID: 15309203 Review.
-
Role of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damage.Clin Exp Nephrol. 2004 Sep;8(3):178-82. doi: 10.1007/s10157-004-0288-9. Clin Exp Nephrol. 2004. PMID: 15480893 Review.
Cited by
-
High-Density Lipoprotein Prevents Endoplasmic Reticulum Stress-Induced Downregulation of Liver LOX-1 Expression.PLoS One. 2015 Apr 29;10(4):e0124285. doi: 10.1371/journal.pone.0124285. eCollection 2015. PLoS One. 2015. PMID: 25923692 Free PMC article.
-
Effects of hydrogen as adjuvant treatment for unstable angina.Exp Biol Med (Maywood). 2021 Sep;246(18):1981-1989. doi: 10.1177/15353702211009138. Epub 2021 Apr 25. Exp Biol Med (Maywood). 2021. PMID: 33899541 Free PMC article.
-
LOX-1, OxLDL, and atherosclerosis.Mediators Inflamm. 2013;2013:152786. doi: 10.1155/2013/152786. Epub 2013 Jul 10. Mediators Inflamm. 2013. PMID: 23935243 Free PMC article. Review.
-
LOX-1 plays an important role in ischemia-induced angiogenesis of limbs.PLoS One. 2014 Dec 16;9(12):e114542. doi: 10.1371/journal.pone.0114542. eCollection 2014. PLoS One. 2014. PMID: 25514797 Free PMC article.
-
Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1.FASEB J. 2013 Mar;27(3):1254-63. doi: 10.1096/fj.12-222216. Epub 2012 Dec 10. FASEB J. 2013. PMID: 23230281 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials